-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Hip fractures are one of the most serious types of fracture injuries and are associated with chronic pain, disability, quality-adjusted loss of life, limited mobility, and significant loss of function, significantly increasing mortality and morbidity in
Many studies have estimated the cumulative incidence of hip fractures, but incidence data can only provide an estimate of an individual's age and sex-related risk over a short period of time, a factor that does not represent lifetime risk because mortality in hip fracture patients is an event rate
While many studies have explored factors associated with hip fracture events, studies of the lifelong risk of hip fractures in patients with type 2 diabetes are still limited and more data are needed to describe the effect of diabetes-related risk factors on the lifetime risk of
A retrospective cohort study was conducted on 25,275 men and 27,953 women with type 2 diabetes who participated in the diabetes case management program
There is a significant difference
Lifetime risk of hip fractures by risk factor subgroup
Considering all age groups, the lifetime risk of hip fractures is not significantly different between women aged < 65 years and men, but the lifetime risk of hip fractures in women after age 65 is much higher than in men
Hip fractures determined by the number of risk factors life expecta-males and b-males
In summary, cumulative lifetime risk provides an additional accurate estimate
References: Lin, C.
